165 related articles for article (PubMed ID: 2848786)
21. A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study).
Choy H; Devore RF; Hande KR; Porter LL; Rosenblatt P; Yunus F; Schlabach L; Smith C; Shyr Y; Johnson DH
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):931-7. PubMed ID: 10863062
[TBL] [Abstract][Full Text] [Related]
22. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
[TBL] [Abstract][Full Text] [Related]
23. Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study.
Lafitte JJ; Ribet ME; Prévost BM; Gosselin BH; Copin MC; Brichet AH
Ann Thorac Surg; 1996 Sep; 62(3):830-4. PubMed ID: 8784014
[TBL] [Abstract][Full Text] [Related]
24. Preoperative radiation therapy in regionally localized stage III non-small cell lung carcinoma: long-term results and patterns of failure.
Reddy S; Faber LP; Baumann LA; Lee MS; Jensik RJ; Kittle FC; Bonomi PD; Taylor SG; Hendrickson FR
Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):287-92. PubMed ID: 2168353
[TBL] [Abstract][Full Text] [Related]
25. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial.
Morton RF; Jett JR; McGinnis WL; Earle JD; Therneau TM; Krook JE; Elliott TE; Mailliard JA; Nelimark RA; Maksymiuk AW
Ann Intern Med; 1991 Nov; 115(9):681-6. PubMed ID: 1656827
[TBL] [Abstract][Full Text] [Related]
26. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
[TBL] [Abstract][Full Text] [Related]
27. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.
Dillman RO; Herndon J; Seagren SL; Eaton WL; Green MR
J Natl Cancer Inst; 1996 Sep; 88(17):1210-5. PubMed ID: 8780630
[TBL] [Abstract][Full Text] [Related]
28. Time to treatment in patients with stage III non-small cell lung cancer.
Wang L; Correa CR; Hayman JA; Zhao L; Cease K; Brenner D; Arenberg D; Curtis J; Kalemkerian GP; Kong FM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):790-5. PubMed ID: 19231108
[TBL] [Abstract][Full Text] [Related]
29. [The effect of levamisole on non-resected lung cancer--the results of randomized controlled study].
Nishimura M; Morishita M; Urata A; Ota K
Gan To Kagaku Ryoho; 1982 Nov; 9(11):1981-93. PubMed ID: 6307178
[TBL] [Abstract][Full Text] [Related]
30. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol.
Blanke C; Ansari R; Mantravadi R; Gonin R; Tokars R; Fisher W; Pennington K; O'Connor T; Rynard S; Miller M
J Clin Oncol; 1995 Jun; 13(6):1425-9. PubMed ID: 7751888
[TBL] [Abstract][Full Text] [Related]
31. Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.
Agolli L; Valeriani M; Bracci S; Nicosia L; DE Sanctis V; Enrici RM; Osti MF
Anticancer Res; 2015 Oct; 35(10):5693-700. PubMed ID: 26408745
[TBL] [Abstract][Full Text] [Related]
32. Limited squamous cell carcinoma of the lung: a Southwest Oncology Group randomized study of radiation with or without doxorubicin chemotherapy and with or without levamisole immunotherapy.
White JE; Chen T; Reed R; Mira J; Stuckey WJ; Weatherall T; O'Bryan R; Samson MK; Seydel HG
Cancer Treat Rep; 1982 May; 66(5):1113-20. PubMed ID: 7044532
[TBL] [Abstract][Full Text] [Related]
33. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
Reboul F; Brewer Y; Vincent P; Chauvet B; Faure CF; Taulelle M
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):343-50. PubMed ID: 8635942
[TBL] [Abstract][Full Text] [Related]
34. Impact of tumor control on survival in carcinoma of the lung treated with irradiation.
Perez CA; Bauer M; Edelstein S; Gillespie BW; Birch R
Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):539-47. PubMed ID: 3009368
[TBL] [Abstract][Full Text] [Related]
35. A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC).
Jain AK; Hughes RS; Sandler AB; Dowlati A; Schwartzberg LS; Dobbs T; Schlabach L; Wu J; Muldowney NJ; Choy H
J Thorac Oncol; 2009 Jun; 4(6):722-7. PubMed ID: 19404213
[TBL] [Abstract][Full Text] [Related]
36. Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients.
Werner-Wasik M; Scott C; Graham ML; Smith C; Byhardt RW; Roach M; Andras EJ
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):327-31. PubMed ID: 10760427
[TBL] [Abstract][Full Text] [Related]
37. A phase II trial of mitomycin C, 5-fluorouracil and radiation therapy in the treatment of unresectable non-small cell lung cancer.
Murren JR; Ganpule S; Papac R; Son YH; Peschel RE; Durivage H; Buzaid AC; Lamb L; Makuch R; Hait WN
Oncol Res; 1993; 5(2):53-7. PubMed ID: 8395915
[TBL] [Abstract][Full Text] [Related]
38. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group.
Sause W; Kolesar P; Taylor S IV; Johnson D; Livingston R; Komaki R; Emami B; Curran W; Byhardt R; Dar AR; Turrisi A
Chest; 2000 Feb; 117(2):358-64. PubMed ID: 10669675
[TBL] [Abstract][Full Text] [Related]
39. Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials.
Cox JD; Scott CB; Byhardt RW; Emami B; Russell AH; Fu KK; Parliament MB; Komaki R; Gaspar LE
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):505-9. PubMed ID: 10078629
[TBL] [Abstract][Full Text] [Related]
40. Local control and survival following concomitant chemoradiotherapy in inoperable stage I non-small-cell lung cancer.
Campeau MP; Herschtal A; Wheeler G; Mac Manus M; Wirth A; Michael M; Hogg A; Drummond E; Ball D
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1371-5. PubMed ID: 19250769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
